Results 151 to 160 of about 93,853 (343)
A Probabilistic Generative Grammar for Semantic Parsing [PDF]
Abulhair Saparov +2 more
openalex +1 more source
Purpose To assess the healing status of ramp lesions repaired using all‐inside devices via second‐look arthroscopy and to identify risk factors associated with healing failure. Methods This study reviewed patients treated between 2016 and 2022 who underwent primary anterior cruciate ligament (ACL) reconstruction with concurrent ramp lesion treatment ...
Hiroaki Fukushima +10 more
wiley +1 more source
The generative grammar of the brain: a critique of internally generated representations. [PDF]
Dragoi G.
europepmc +1 more source
Design Of Generative Model For The Language Of Traditional Suakin Using Parametric Shape Grammar
Olakanbi Bolaji AbdulRaheem +1 more
openalex +1 more source
LEXICOGRAPHY AND GENERATIVE GRAMMAR I: HEDGES AND MEANING CRITERIA * [PDF]
George Lakoff
openalex +1 more source
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro +17 more
wiley +1 more source
A Generative - Transformational Grammar of the Kikuyu Language Based on the Nyeri Dialect.
Harold J Overton, Harold Overton
openalex +2 more sources
Objective Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter 2 inhibitors (SGLT2i) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear.
Derin Karacabeyli +4 more
wiley +1 more source
Affirming generative artificial intelligence as a co-pilot, not a co-author, in medical and scientific writing. [PDF]
Wattanapisit A +2 more
europepmc +1 more source
Objective Rituximab, a CD20+ B cell depletion therapy, is frequently used to treat systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopulation.
Haerin Jang +9 more
wiley +1 more source

